共 95 条
[1]
Barber MRW(2021)Global epidemiology of systemic lupus erythematosus Nat Rev Rheumatol 17 515-532
[2]
Drenkard C(2020)Clinical significance of non-thyroidal illness syndrome on disease activity and dyslipidemia in patients with SLE PLoS ONE 15 e0231622-1607
[3]
Falasinnu T(2022)Nonthyroidal illness syndrome: to treat or not to treat? Have we answered the question? A review of metanalyses Front Endocrinol(Lausanne) 10 850328-220
[4]
Hoi A(2021)An update on non-thyroidal illness syndrome J Endocrinol Invest 44 1597-495
[5]
Mak A(2011)The nonthyroidal illness syndrome in the non-critically ill patient Eur J Clin Invest 41 212-215
[6]
Kow NY(2023)The role of first-trimester NLR(neutrophil to lymphocyte ratio), systemic immune-inflammation index(SII), and systemic immune-response index (SIRI) in the prediction of composite adverse outcomes in pregnant women with systemic lupus erythematosus J Reprod Immunol 12 103978-570
[7]
Svenungsson E(2011)The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases Intern Emerg Med 6 487-78
[8]
Peterson J(2009)Interleukin-17 and systemic lupus erythematosus: current concepts Clin Exp Immunol 157 209-1845
[9]
Clarke AE(2000)Cytokine production, serum levels and disease activity in systemic lupus erythematosus Clin Exp Rheumatol 18 565-825
[10]
Ramsey-Goldman R(2012)Roles of pro- and anti-inflammatory cytokines in the pathogenesis of SLE J Biomed Biotechnol 2012 347141-114